Outcome of 12-weeks Triple Therapy (TT), including Sofosbuvir (SOF), Ribavirin and Pegylated interferon-Alfa in all non-cirrhotic patients with chronic Hepatitis-C Genotype-3 infection. Medical Forum Monthly, [S. l.], v. 28, n. 7, 2024. Disponível em: https://medicalforummonthly.com/index.php/mfm/article/view/4148.. Acesso em: 16 nov. 2025.